Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krutika Amin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Managed Care & Specialty Pharmacy|February 24, 2017
Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline AdherenceKrutika Amin, Joel F Farley, Matthew L Maciejewski, et al.
Journal of Neurotrauma|February 21, 2013
Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical exampleChristian Niyonkuru, Amy K Wagner, Haishin Ozawa, et al.
Medical Care|November 6, 2019
A Comparison of Health Risk and Costs Across Private Insurance MarketsBrett Lissenden, Krutika Amin, Kelly Drury, et al.
Medical Care|February 4, 2020
Incorporating Prescription Drugs Into Affordable Care Act Risk AdjustmentGregory C Pope, Andrew Pearlman, Melvin J Ingber, et al.
Journal of Neurotrauma|November 30, 2012
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injuryAkash Goyal, Michelle D Failla, Christian Niyonkuru, et al.
Plos One|November 29, 2021
Providers' mediating role for medication adherence among cancer survivorsJustin G Trogdon, Krutika Amin, Parul Gupta, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Managed Care & Specialty Pharmacy|February 24, 2017
Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline AdherenceKrutika Amin, Joel F Farley, Matthew L Maciejewski, et al.
Journal of Neurotrauma|February 21, 2013
Group-based trajectory analysis applications for prognostic biomarker model development in severe TBI: a practical exampleChristian Niyonkuru, Amy K Wagner, Haishin Ozawa, et al.
Medical Care|November 6, 2019
A Comparison of Health Risk and Costs Across Private Insurance MarketsBrett Lissenden, Krutika Amin, Kelly Drury, et al.
Medical Care|February 4, 2020
Incorporating Prescription Drugs Into Affordable Care Act Risk AdjustmentGregory C Pope, Andrew Pearlman, Melvin J Ingber, et al.
Journal of Neurotrauma|November 30, 2012
S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injuryAkash Goyal, Michelle D Failla, Christian Niyonkuru, et al.
Plos One|November 29, 2021
Providers' mediating role for medication adherence among cancer survivorsJustin G Trogdon, Krutika Amin, Parul Gupta, et al.
Pageof 1